-- Preview Email Newsletter
| Journals Biology Newsletter for 2026-10-14 ( 6 items ) |
|
Annual Douthat lecture to examine race, medicine, and art in Harlem (10)
WILLIAMSPORT, Pennsylvania, Oct. 13 -- Lycoming College posted the following news:
* * *
Annual Douthat lecture to examine race, medicine, and art in Harlem
*
Lycoming College will host art historian Tanya Sheehan, Ph.D., for a talk titled "Communities of Care: Jacob Lawrence and the Murals of Harlem Hospital," on Wednesday, Oct. 21, at 7:30 p.m., in the Trogner Presentation Room in Krapf Gateway Center. The event is free and open to the public with a reception to follow.
In the late 1930s, as federally funded artists painted large-scale m more PR
Continuously Evolving Cells Help Pancreatic Cancer Evade Treatment and Spread (10)
NEW YORK, Oct. 13 [Category: BizHospital] -- NYU Langone Health, an academic medical center affiliated with New York University, posted the following news release:
* * *
Continuously Evolving Cells Help Pancreatic Cancer Evade Treatment and Spread
*
An analysis of nearly half a million cells from dozens of patients' tumors reveals how cancer cells continuously reshape their genetic makeup over time, enabling them to evade treatment for one of the deadliest forms of cancer.
Led by researchers at NYU Langone Health and its Perlmutter Cancer more PR
Heidelberg University: Synthetic Cells - Function Through Mutation (10)
HEIDELBERG, Germany, Oct. 13 (TNSjou) -- Heidelberg University issued the following news release:
* * *
Synthetic Cells: Function Through Mutation
13 October 2026
Just a few genetic changes transform simple RNA droplets into cell-like structures that can move and take up cargo
-
A small number of random genetic mutations cause simple RNA droplets to transform into cell-like structures. In this process, they form cavities, can move and are able to take up cargo. This has been demonstrated through research using nanostructures based on ribo more PR
London Institute of Cancer Research: New Study Reveals Unexpected Critical Target of a Common Research Tool and Related Cancer Drug That Entered Clinical Trial (10)
LONDON, England, Oct. 13 (TNSjou) -- The Institute of Cancer Research issued the following news:
* * *
New study reveals the unexpected critical target of a common research tool and related cancer drug that entered clinical trial
13/10/26
Scientists have uncovered that an important chemical 'probe' compound widely used to study cancer in the lab - and also a related compound that has entered clinical evaluation in cancer patients - do not in fact work in brain cancer cells via their long-believed mechanism of action. Instead, they act on a more PR
UCLA Health Jonsson Comprehensive Cancer Center: Scientists Identify Clues to Making Immunotherapy More Effective Against Glioblastoma (10)
LOS ANGELES, California, Oct. 14 (TNSjou) -- The UCLA Health Jonsson Comprehensive Cancer Center issued the following news release:
* * *
Scientists identify clues to making immunotherapy more effective against glioblastoma
Two UCLA-led studies identify features of effective immune responses in glioblastoma and introduce a preclinical model that more closely mirrors the human disease
October 13, 2026
Two new studies led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center provide new insight into how the immune system can more PR
University of Delaware Researchers Develop Groundbreaking In-Cell Plant Proteomics Technique (10)
DOVER, Delaware, Oct. 14 (TNSjou) -- The University of Delaware issued the following research news:
* * *
Plant biology breakthrough
Article by Karen B. Roberts October 13, 2026
UD-developed method helps researchers study proteins involved in plant health, disease
-
Plants -- like people -- come in all shapes and sizes.
And just like scientists want to understand the components of the human body, to treat disease and improve our lives, they also want to understand how plants thrive, get disease, succumb or survive.
It's a real problem more PR
|
